Pro Q Kine approved: ID612158 (31 points Manual Therapy – 24 points National Symposium)
Scientific Program
Please find below the Scientific Program for the International Dupuytren Conference on May 16th and 17th 2025 at the Nhow Brussels Bloom Hotel. In case of changes of this program this page will be updated accordingly. The conference will start on Friday, 16 May, at 9 am and on that day the program will end around 6:30 pm. On Saturday the conference will start at 8:30 am, and we are expecting to close the conference at 6:30 pm.
Friday, May 16
09:00 Welcome – Bernard Lefebvre, Rozemie Zenner, Ilse Degreef
09:10 Opening Address – Wolfgang Wach
09:25 Session 1: Pathophysiology – Dominic Furniss, Charles Eaton
09:25 Pathogenesis of Dupuytren’s Disease – Charles Eaton
09:40 Genetics of Dupuytren disease – Dominic Furniss
09:55 Associations of demographic, lifestyle and clinical factors with the presence of Dupuytren’s disease: results from the Lifelines Cohort Study – Michel Noordman
10:02 Metabolic Determinants in Dupuytren’s Disease: A Mendelian Randomisation Analysis – Max Butler
10:09 Polygenic risk score predicts recurrence, its severity, and retreatment for Dupuytren’s disease – Sophie Riesmeijer
10:16 Investigating Genes of Interest in Dupuytren Disease – Ben Christensen
10:23 Discussion
10:38 Coffee Break and visit of the exhibitors
11:08 Session 2: Cellular Biology – David O’Gorman, Ilse Degreef
11:08 (Extra)cellular Events in Dupuytren’s Disease – Boris Hinz
11:23 Controversies in Cellular Events – David O’Gorman
11:38 The abnormal mechanotransduction response of Dupuytren’s fibroblasts from patients with the disease-associated MMP14 Single Nucleotide Polymorphism – Mira Pecheva
11:45 Demographics and Clinical Outcomes of Dupuytren’s Contracture: A Retrospective Case Series – Steve Mullings
11:52 The presence of microvascular structures in Dupuytren’s disease on ultrasound images: A case study – Leander Swinnen
11:59 Discussion
12:14 Industry Workshops
12:44 Lunch break and visit of the exhibitors
13:44 Session 3: Assessment & Therapeutic Management – Jagdeep Nanchahal, Donna Kennedy
13:44 Early Disease Treatment of Dupuytren’s – Jagdeep Nanchahal
13:59 Hand therapy in managing fibrosis, soft-tissue attenuation and scarring in the post-surgical hand. Why is the PIP joint such a jerk? – Donna Kennedy
14:14 Splinting in Dupuytren – evidence based therapy? – Sonja Pelzmann
14:29 Modern approach to the classification of Dupuytren’s disease – Andrey Zhigalo
14:36 Sensitivity of the outcome measurements used for evaluating treatment effectiveness in Dupuytren´s disease – Teemu Karjalainen
14:43 Agreement between photographic and goniometric measurements of Dupuytren’s contracture – a DISC substudy – Nick Johnson
14:50 Sensor-Controlled Patient Compliance with Postoperative Splinting after Dupuytren’s Surgery – Bram Van Hove
14:57 Preoperative serial casting, stretching, and massage therapy will improve surgical outcomes in Dupuytren’s fasciectomy patients with severe proximal interphalangeal (PIP) joint contracture – Tahra Babiker-Moore
15:04 The use of Virtual Reality during hand therapy after Dupuytren surgery – Tom Lattré
15:11 Dynamic Low-force Finger Stretching in Dupuytren’s Patients by Use of an Orthosis; Post Product Development Case Studies – Lotte Lammers
15:18 Discussion
15:33 Coffee Break and visit of the exhibitors
16:03 Session 4: Minimal invasive treatment of Dupuytren contracture –
Gary Pess, Esther Vögelin
16:03 Comparative Studies of Treatments – Tim Davis
16:18 Minimally Invasive Treatments – Gary Pess
16:33 Ultrasound in Dupuytren Diagnosis and Treatment – Esther Vögelin
16:48 Discussion
17:03 Long-term assessment of collagenase treatment for Dupuytren’s contracture: A 10-year follow-up study – Vitale Cilli
17:10 Collagenase injection compared with limited fasciectomy for moderate Dupuytren Contracture: the DISC non-inferiority RCT – Nick Johnson
17:17 Comparison of contracture recurrence after fasciectomy, needle aponeurotomy or collagenase Clostridium histolytium: A systematic review of prospective data with minimum 2-year follow-up – Mark Vitale
17:24 Collagenase Clostridium histolyticum is an effective treatment of contracture recurrence after surgery: A retrospective multicenter series – Mark Vitale
17:31 Re-Recurrence Rate Two Years after Fasciectomy vs Collagenase in Recurrent Contracture: Randomized Controlled Trial – Isam Atroshi
17:38 Safety and effectiveness of Percutaneous Sonographically Guided Release (PSGR) for Dupuytren’s contractures – A case series of 76 patients – Fabian Moungondo
17:45 Belgian Hand Group – General Assembly – Bernard Lefebvre
17:45 Workshop on Wound repair & Endermologie
18:30 End of Day
19:30 Congress dinner – Culinary Walking Tour of Brussels
Saturday, May 17
08:30 Session 5: Radioprotection & Radiotherapy in Hand Surgery – Jarad Martin, Richard Shaffer
08:30 Radioprotection in hand surgery – Hilde Bosmans
09:30 Radiotherapy for Dupuytren’s and related conditions – Jarad Martin
09:45 Radiotherapy in clinical practice – Richard Schaffer
10:00 Discussion
10:15 Coffee Break and visit of the exhibitors
10:45 A Comparative Longitudinal Observational Cohort Study of Fractionated Superficial Radiotherapy Treatment of Dupuytren’s Disease – Henry Weatherburn
10:52 Clinical Implementation of 3D-Printed compensator for Dupuytren Electron Radiotherapy – David Roberge
10:59 Radiotherapy for symptomatic knuckle pads/Garrod’s nodes: Report of a case series – Elisabeth Weiss
11:06 Radiotherapy for Ledderhose disease: Results of the LedRad-study, a prospective multicentre randomised double-blind phase III trial – Anneke de Haan
11:13 Evaluating the Safety and Efficacy of Adjuvant Radiation Therapy in combination with Contracture Release: A Prospective Study – Leslie Chang
11:20 Discussion
11:35 Session 6: Surgical treatment of Dupuytren contracture and related diseases – Jean-Paul Brutus, Bernard Lefebvre
11:35 WALANT in hand surgery: Technique and indication – Donald Lalonde (online)
11:50 WALANT in hand surgery for Dupuytren: Results and patients experience – Jean-Paul Brutus
12:05 The WALANT Approach to Dupuytren’s Disease – Outcomes and Perspectives – Laoise Kenny
12:12 Discussion
12:27 Industry Workshops
12:57 Lunch break and visit of the exhibitors
13:57 Surgical Treatment: Dermo-fasciectomy – Dominique Davidson
14:12 Peyronie’s Disease: Diagnosis and Treatment – David Ralph
14:27 Outcomes of limited fasciectomy, needle fasciotomy and collagenase in Dupuytren’s disease – a systematic review and meta-analysis of individual patient data – Bente van den Berge
14:34 Progression of Dupuytren’s contracture: a secondary analysis of a randomized controlled trial comparing surgery, needle fasciotomy, and collagenase injection – Teemu Karjalainen
14:41 The Likelihood of Further Dupuytren Disease Intervention After Initial Treatment – Rayan El Bachaoui
14:48 The added value of skin grafting in surgery for Dupuytren’s contracture: an effective method for severe cases with a low recurrence rate – Francine Vos
14:55 McCash`s old not often used technique in severe Dupuytren`s disease – Bernard Lukas
15:02 Discussion
15:17 Session 7: Salvage in Dupuytren treatment: when all else fails – Jean Goubau, Rozemie Zenner
15:17 Salvage Procedures for Recurrent Dupuytren’s Disease – Jean Goubau
15:32 Dupuytren’s Disease Under the Microscope – Ilse Degreef
15:39 Arthrolysis of PIP joint in Dupuytren’s contracture – Floor Van den Eynde
15:46 Treatment of severe forms of Dupuytren’s contracture using a modified mini-Ilizarov apparatus – Alexander Zolotov
15:53 Long-term results of the Malingue technique in the surgical treatment of Dupuytren’s disease – Alexandre Petit
16:00 Middle phalangectomy with shortening fusion of the fifth finger in Dupuytren’s digital hooks – Alexandre Petit
16:07 Proximo-Distal Interphalangeal Arthrodesis as a First-Line Treatment for Severe Contracture of the Fifth Finger: Key Insights and Pitfalls to Avoid – Caro Roten
16:14 Discussion
16:29 Coffee Break and visit of the exhibitors
16:59 Session 8: Ethical Considerations and Patient Perspectives – Anna Schurer, Paul Werker
16:59 Ethical Considerations and Patient Perspectives – Anna Schurer
17:14 Philosophy of treatment surgery – Paul Werker
17:29 Clinician-patient collaboration: assessment, outcome measures and shared decision making – Ruud Selles
17:44 Patient Perspectives on Dupuytren’s Contracture Treatments: A Sentiment Analysis of Social Media Comments – Cameron Sabet
17:51 An economic evaluation of radiotherapy for patients with symptomatic Ledderhose disease – Anneke de Haan
17:58 Dupuytren’s disease in General Practitioner care – Roel Van Straalen
18:03 Silent Signals: From Hands to Heart – Ethical Imperatives in Dupuytren, Carpal Tunnel, and Amyloidosis – Arne Decramer
18:08 Discussion
18:22 Closing Words – Ilse Degreef
18:27 End of Congress
Organizing Committee
Prof. Ilse Degreef, UZ Leuven, Belgium
supported by
Dr. Charles Eaton, Dupuytren Research Group, USA
Prof. Dominic Furniss, NDORMS, Oxford, UK
Prof. David O’Gorman, The University of Western Ontario, Canada
Anna Schurer, International Dupuytren Society
Prof. Paul Werker, UMC Groningen, The Netherland